Transcriptional mechanisms for the Wilms’ tumor gene 1 (WT1) oncoprotein
1 – 15 of 28
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies
(
- Contribution to journal › Article
-
Mark
Lin28b controls a neonatal to adult switch in B cell positive selection
(
- Contribution to journal › Article
-
Mark
Searching for WT1 target genes in leukemic cell lines
(
- Thesis › Doctoral thesis (compilation)
- 2018
-
Mark
Target Genes of WT1 in Leukemic Cells
2018) Scientific Symposium -European Academy for Biomedical Science(
- Contribution to conference › Poster
-
Mark
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
(
- Contribution to journal › Article
-
Mark
Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
(
- Contribution to journal › Article
- 2017
-
Mark
Distinct global binding patterns of the Wilms' tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells
(
- Contribution to journal › Article
-
Mark
The transcriptional coregulator NAB2 is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells
(
- Contribution to journal › Article
-
Mark
Direct evidence for a polygenic etiology in familial multiple myeloma
(
- Contribution to journal › Article
-
Mark
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
(
- Contribution to journal › Article
- 2016
-
Mark
The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
(
- Contribution to journal › Article
- 2015
-
Mark
The DEK oncoprotein and its emerging roles in gene regulation.
(
- Contribution to journal › Scientific review
-
Mark
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene.
(
- Contribution to journal › Article
- 2014
-
Mark
The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
(
- Contribution to journal › Article